414
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Predictive Value of Selected Biomarkers, Polymorphisms, and Clinical Features for Oligoarticular Juvenile Idiopathic Arthritis-associated Uveitis

, PhD, , PhD, , PhD, , MD, , MD, , PhD, , PhD, , MSc & , PhD show all

References

  • Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis: why does it vary so much? J Rheumatol. 2002 Jul;29:1520–1530
  • Zak M, Pedersen FK. Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology. 2000; 39:198–204
  • Cassidy JT, Petty RE. Chronic arthritis in childhood. In: Cassidy JT, Petty RE, eds. Textbook of Pediatric Rheumatology, 5th ed. Philadelphia: Elsevier Saunders; 2005:206–260
  • Grassi A, Corona F, Casellato A, et al. Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease. J Rheumatol. 2007;34: 1139–1145
  • Heiligenhaus A, Niewerth M, Ganser G, et al.; and the German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current guidelines. Rheumatology. 2007; 46:1015–1019
  • Demirkaya E, Ozen S, Bilginer Y. The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol. 2011 Jan-Feb; 29:111–116. Epub 2011 Feb 23
  • Saurenmann RK, Levin AV, Feldman BM, et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Arthritis Rheum. 2007 Feb;56:647–657
  • Bolt IB, Cannizzaro E, Seger R, Saurenmann RK. Risk factors and longterm outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. J Rheumatol. 2008 Apr;35:703–706
  • Kanski JJ. Screening for uveitis in juvenile chronic arthritis. Br J Ophthalmol. 1989;73:225–228
  • Sim KT, Venning HE, Barrett S, et al. Extended oligoarthritis and other risk factors for developing JIA-associated uveitis under ILAR classification and its implication for current screening guideline. Ocul Immunol Inflamm. 2006; 14:353–357
  • Zulian F, Martini G, Falcini F, et al. Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis. J Rheumatol. 2002;29:2446–2453
  • Kotaniemi K, Kiapiainen-Seppänen O. A population-based study on uveitis in juvenile rheumatoid arthritis. Clin Exp Rheumatol. 1999;17:234-235
  • Kanski JJ. Juvenile arthritis and uveitis. Surv Ophthalmol. 1990;34:253–267
  • Carvounis PE, Herman DC, Cha S, Burke JP. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefes Arch Clin Exp Ophthalmol. 2006;244:281–290
  • Petty RE, Southwood TR, Manners P, et al.; and the International League of Associations for Rheumatology. International League of Associations for Rheumatology Classification of Juvenile Idiopathic Arthritis, second revision, Edmonton, 2001. J Rheumatol. 2004 Feb;31:390–392
  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516
  • Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;94:3195–3199
  • Zienolddiny S, Ryberg D, Maggini V, et al. Polymorphism of the interleukin-1 β gene are associated with increased risk of non–small cell lung cancer. Int J Cancer. 2004;109:353–356
  • Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plana IL-6 levels. J Clin Invest. 1998;102:1369–1376
  • Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukine-10 gene promoter. Eur J Immunogenet. 1997;24:1–8
  • Rafiq S, Stevens K, Hurst AJ, et al. Common genetic variation in the gene encoding interleukin-1 receptor antagonist (IL1-RA) is associated with altered circulating IL1RA levels. Genes Immun. 2007;8:344–351
  • Woreta F, Thorne JE, Jabs DA, et al. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;143:647–655
  • Cassidy J, Kivlin J, Lindsley C, Nocton J. Section on Rheumatology; Section on Ophthalmology. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 2006;117:1843--1845
  • Zannin ME, Buscain I, Vittadello F, et al. Timing of uveitis onset in oligoarticular juvenile idiopathic arthritis (JIA) is the main predictor of severe course uveitis. Acta Ophthalmol. 2012 Feb;90:91–95
  • Oren B, Sehgal A, Simon JW, et al. The prevalence of uveitis in juvenile rheumatoid arthritis. JAAPOS. 2001;5:2–4
  • Mangge H, Kenzian H, Gallistl S, et al. Serum cytokines in juvenile rheumatoid arthritis: correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum. 1995;38:211–220
  • Ou LS, See LC, Wu CJ, et al. Association between serum inflammatory cytokines and disease activity in juvenile idiopathic arthritis. Clin Rheumatol. 2002;21:52–56
  • Lopez-Diaz MJ, Llorca J, Gonzalez-Juanatey C, et al. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis. Semin Arthritis Rheum. 2008 Oct;38:116–123

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.